| 2025 | 2024 | 2023 | ||||
|---|---|---|---|---|---|---|
| Gross margin | -14,3 k € | +78.6% | -66,7 k € | +44.8% | -120,9 k € | |
| EBITDA | -203,3 k € | -4.7% | -194,2 k € | +28.7% | -272,3 k € | |
| Operating profit | -298,6 k € | -6.8% | -279,7 k € | +15.2% | -329,8 k € | |
| Profit/loss | -322,3 k € | -9.3% | -294,8 k € | +11.1% | -331,5 k € | |
| Equity | -272,9 k € | -653.2% | 49,3 k € | -74.6% | 194,1 k € | |
| Total assets | 1,2 M € | -28.9% | 1,7 M € | +332.1% | 402,4 k € | |
| Cash | 173,5 k € | -54.5% | 381,8 k € | +523.8% | 61,2 k € | |
| Debts | 760,0 k € | +69.7% | 447,9 k € | +416.3% | 86,8 k € | |
| Staff | 4 | 2,8 | — | |||
Source: Belgian Official Gazette
Private limited company · Gent · incorporated on 04/04/2022 · 4,0 ETP
Private limited company loss-making in the latest fiscal year. Cash position declining (-54.5%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
Key indicators
BIO INX is a Private limited company incorporated in 2022. Its main activity is: Research and experimental development on natural sciences and engineering. Its registered office is in Gent. It employs on average 4,0 ETP workers (FTE).